Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis

• Published in: Arthritis research & therapy Vol. 12; no. 4; p. R129
• Main Authors: Wong, Chun K, Chen, Da P, Tam, Lai S, Li, Edmund K, Yin, Yi B, Lam, Christopher WK
• Format: Journal Article
• Language: English
• Published: London BioMed Central 01.01.2010; BioMed Central Ltd
• Subjects: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid - immunology; Arthritis, Rheumatoid - pathology; Cells, Cultured; Cellular signal transduction; Cytokine Receptor gp130 - genetics; Cytokine Receptor gp130 - immunology; Cytokines; Female; Fibroblasts - drug effects; Fibroblasts - immunology; Fibroblasts - pathology; Flow Cytometry; Humans; Inflammation; Intercellular Adhesion Molecule-1 - metabolism; Interleukin-1beta - immunology; Interleukin-1beta - metabolism; Interleukin-1beta - pharmacology; Interleukins - blood; Interleukins - immunology; Interleukins - pharmacology; Male; Medicine; Medicine & Public Health; Middle Aged; Orthopedics; Physiological aspects; Receptors, Interleukin - genetics; Receptors, Interleukin - immunology; Research Article; Rheumatoid arthritis; Rheumatology; RNA, Messenger - metabolism; Signal Transduction - immunology; Synovial Membrane - immunology; Synovial Membrane - metabolism; Synovial Membrane - pathology; Synovial membranes; Tumor necrosis factor; Tumor Necrosis Factor-alpha - immunology; Tumor Necrosis Factor-alpha - metabolism; Tumor Necrosis Factor-alpha - pharmacology; Vascular Cell Adhesion Molecule-1 - metabolism; Mean Fluorescence Intensity; Established Rheumatoid Arthritis; Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Mouse IgG1 Isotypic Control
• ISSN: 1478-6354; 1478-6362; 1478-6354; 1478-6362
• DOI: 10.1186/ar3067

Introduction Interleukin (IL)-27 is a novel member of the IL-6/IL-12 family cytokines that are produced early by antigen-presenting cells in T helper (Th)1-mediated inflammation. Elevated expression of IL-27 has been detected in the synovial membranes and fluid of rheumatoid arthritis (RA). Methods We investigated the in vitro effects of IL-27, alone or in combination with inflammatory cytokine tumor necrosis factor (TNF)-α or IL-1 β on the pro-inflammatory activation of human primary fibroblast-like synoviocytes (FLS) from RA patients and normal control subjects, and the underlying intracellular signaling molecules were determined by intracellular staining using flow cytometry. Results Significantly higher plasma concentration of IL-27 was found in RA patients ( n = 112) than control subjects ( n = 46). Both control and RA-FLS constitutively express functional IL-27 receptor heterodimer, gp130 and WSX-1, with more potent IL-27-mediated activation of signal transducers and activators of transcription (STAT)1 in RA-FLS. IL-27 was found to induce significantly higher cell surface expression of intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 and release of inflammatory chemokine IL-6, CCL2, CXCL9, CXCL10 and matrix metalloproteinase-1 of RA-FLS than that of control FLS (all P < 0.05). Moreover, an additive or synergistic effect was observed in the combined treatment of IL-27 and TNF-α or IL-1 β on the surface expression of ICAM-1 and VCAM-1 and the release of CXCL9 and CXCL10 of RA-FLS. Further investigations showed that the expression of ICAM-1, VCAM-1 and chemokines stimulated by IL-27 was differentially regulated by intracellular activation of phosphatidylinositol 3-OH kinase-AKT, c-Jun amino-terminal kinase and Janus kinase pathways. Conclusions Our results therefore provide a new insight into the IL-27-activated immunopathological mechanisms mediated by distinct intracellular signal transductions in joint inflammation of RA.